Real-world experience of vedolizumab use in Colombian patients with inflammatory bowel disease—EXVEDOCOL

Real-world studies about the effectiveness and safety of vedolizumab (VDZ) in the treatment of inflammatory bowel disease (IBD) in Latin America are scarce. Our study describes the effectiveness and safety of VDZ in Colombian patients with IBD.